BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8505104)

  • 21. Effect of salt intake and inhibitor dose on arterial hypertension and renal injury induced by chronic nitric oxide blockade.
    Yamada SS; Sassaki AL; Fujihara CK; Malheiros DM; De Nucci G; Zatz R
    Hypertension; 1996 May; 27(5):1165-72. PubMed ID: 8621212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition.
    Pollock DM; Polakowski JS; Divish BJ; Opgenorth TJ
    Hypertension; 1993 May; 21(5):660-6. PubMed ID: 7684026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker.
    Ruzicka M; Yuan B; Harmsen E; Leenen FH
    Circulation; 1993 Mar; 87(3):921-30. PubMed ID: 8443912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II: endothelium-derived nitric oxide interaction in conscious rats.
    Sigmon DH; Newman JM; Beierwaltes WH
    J Am Soc Nephrol; 1994 Mar; 4(9):1675-82. PubMed ID: 8011977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tonic stimulation of renin gene expression by nitric oxide is counteracted by tonic inhibition through angiotensin II.
    Schricker K; Hegyi I; Hamann M; Kaissling B; Kurtz A
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):8006-10. PubMed ID: 7644529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats.
    Gardiner SM; Compton AM; Kemp PA; Bennett T; Foulkes R; Hughes B
    Br J Pharmacol; 1991 May; 103(1):1256-62. PubMed ID: 1878760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal nitric oxide and angiotensin II interaction in renovascular hypertension.
    Sigmon DH; Beierwaltes WH
    Hypertension; 1993 Aug; 22(2):237-42. PubMed ID: 8340159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N(G)-nitro-L-arginine methyl ester-induced hypertension and natriuretic peptide gene expression: inhibition by angiotensin II type 1 receptor antagonism.
    Suo M; Kalliovalkama J; Pörsti I; Jolma P; Tolvanen JP; Vuolteenaho O; Ruskoaho H
    J Cardiovasc Pharmacol; 2002 Sep; 40(3):478-86. PubMed ID: 12198334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
    Hartman JC
    Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of nitric oxide and angiotensin II in the regulation of sympathetic nerve activity in spontaneously hypertensive rats.
    Kumagai H; Averill DB; Khosla MC; Ferrario CM
    Hypertension; 1993 Apr; 21(4):476-84. PubMed ID: 8384603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension.
    Cachofeiro V; Maeso R; Rodrigo E; Navarro J; Ruilope LM; Lahera V
    Hypertension; 1995 Aug; 26(2):236-43. PubMed ID: 7635531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular responsiveness to nitric oxide synthesis inhibition in hypertensive rats.
    Pucci ML; Miller KB; Dick LB; Guan H; Lin L; Nasjletti A
    Hypertension; 1994 Jun; 23(6 Pt 1):744-51. PubMed ID: 8206572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salt-sensitive hypertension resulting from nitric oxide synthase inhibition is associated with loss of regulation of angiotensin II in the rat.
    Hodge G; Ye VZ; Duggan KA
    Exp Physiol; 2002 Jan; 87(1):1-8. PubMed ID: 11805851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of losartan and enalapril on renal adaptation sodium restriction in rat.
    Jover B; Saladini D; Nafrialdi N; Dupont M; Mimran A
    Am J Physiol; 1994 Aug; 267(2 Pt 2):F281-8. PubMed ID: 8067389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of nitric oxide, but not prostaglandins, in the vascular sympathoinhibitory effects of losartan in the pithed spontaneously hypertensive rat.
    Richer C; Domergue V; Vincent MP; Giudicelli JF
    Br J Pharmacol; 1996 Jan; 117(2):315-24. PubMed ID: 8789385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of angiotensin II infusion and inhibition of nitric oxide synthase on the rat aorta.
    Kato H; Hou J; Chobanian AV; Brecher P
    Hypertension; 1996 Aug; 28(2):153-8. PubMed ID: 8707375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide.
    Munoz-Garcia R; Maeso R; Rodrigo E; Navarro J; Ruilope LM; Casal MC; Cachofeiro V; Lahera V
    J Hypertens; 1995 Dec; 13(12 Pt 2):1779-84. PubMed ID: 8903651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional haemodynamic responses to pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide in conscious rats.
    Gardiner SM; Rakhit T; Kemp PA; March JE; Bennett T
    Br J Pharmacol; 1994 Feb; 111(2):589-97. PubMed ID: 7911721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II blockade does not prevent renal effects of L-NAME in sodium-repleted humans.
    Montanari A; Tateo E; Fasoli E; Giberti D; Perinotto P; Novarini A; Dall'Aglio P
    Hypertension; 1997 Sep; 30(3 Pt 2):557-62. PubMed ID: 9322981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.